scholarly journals Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer

2021 ◽  
Author(s):  
Aurelia Ada Guarini
Keyword(s):  
Lung Cancer ◽  
Narrative Review ◽  
Tumor Boards

scholarly journals Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer

2021 ◽  
Author(s):  
Vittorio Gebbia ◽  
Aurelia Guarini ◽  
Dario Piazza ◽  
Alessandro Bertani ◽  
Massimiliano Spada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Narrative Review ◽  
Tumor Boards

scholarly journals The use of aerosol generating procedures (AGPs) during the COVID-19 pandemic in the diagnosis of lung cancer: a narrative review

Mediastinum ◽  
2021 ◽  
Vol 0 ◽  
pp. 0-0
Author(s):  
Siyamini Vythilingam ◽  
Matthew Quint ◽  
Richard Newsom ◽  
Alexander Hicks
Keyword(s):  
Lung Cancer ◽  
Narrative Review ◽  
Diagnosis Of Lung Cancer

scholarly journals Non-intubated VATS for lung cancer—a focus on segmentectomy: a narrative review

2021 ◽  
Vol 0 ◽  
pp. 0-0
Author(s):  
Cristina Diotti ◽  
Shehab Mohamed ◽  
Margherita Cattaneo ◽  
Francesco Damarco ◽  
Davide Tosi
Keyword(s):  
Lung Cancer ◽  
Narrative Review

scholarly journals The role of sonographic patterns during endobronchial ultrasound-transbronchial needle aspiration for lung cancer staging: a narrative review

Mediastinum ◽  
2021 ◽  
Vol 5 ◽  
pp. 8-8
Author(s):  
Mario Nosotti ◽  
Michele Ferrari ◽  
Ilaria Righi ◽  
Paolo Mendogni ◽  
Francesco Damarco ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Staging ◽  
Needle Aspiration ◽  
Narrative Review ◽  
Endobronchial Ultrasound ◽  
Transbronchial Needle Aspiration ◽  
Sonographic Patterns

scholarly journals Does Pemetrexed Work in Targetable, Nonsquamous Non-Small-Cell Lung Cancer? A Narrative Review

Cancers ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2658
Author(s):  
Jin-Yuan Shih ◽  
Akira Inoue ◽  
Rebecca Cheng ◽  
Rocio Varea ◽  
Sang-We Kim
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Advanced Nsclc ◽  
Small Cell ◽  
Narrative Review ◽  
Small Cell Lung ◽  
First Line ◽  
Anaplastic Lymphoma

Pemetrexed is currently mainly considered for the treatment of advanced nonsquamous non-small-cell lung cancer (NSCLC) negative for gene mutations/rearrangements (wild-type disease (WTD)). This narrative review aimed to highlight the role of pemetrexed in the treatment of onco-driven nonsquamous advanced NSCLC by reviewing published clinical studies. For epidermal growth factor receptor (EGFR) mutations, patient survival following first-line pemetrexed–platinum was longer than for WTD. Later-line pemetrexed-based treatment after tyrosine kinase inhibitor (TKI) failure provided greater benefits than non-pemetrexed regimens. First- and later-line pemetrexed-based therapy also provided survival benefits in patients with anaplastic lymphoma kinase (ALK) or ROS proto-oncogene 1 (ROS1) rearrangements. In patients with rearranged during transfection (RET) proto-oncogene rearrangements, survival with pemetrexed was similar to that in ALK- and ROS1-positive patients and longer than that in patients with Kirsten rat sarcoma (KRAS) virus proto-oncogene mutations or WTD, although the available studies were limited. For Erb-b2 receptor tyrosine kinase 2 (ERRB2) mutations, first-line pemetrexed showed outcomes similar to those for EGFR and KRAS alterations. Data on pemetrexed in patients with KRAS mutations or MNNG HOS-transforming (MET) expression were limited. Pemetrexed could be an option for first- and second-line treatment for TKI failure in nonsquamous advanced NSCLC with select targetable driver mutations.

scholarly journals Immunotherapy in small cell lung cancer: one step at a time: a narrative review

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Daphne W. Dumoulin ◽  
Anne-Marie C. Dingemans ◽  
Joachim G. J. V. Aerts ◽  
Jordi Remon ◽  
Dirk K. M. De Ruysscher ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Narrative Review ◽  
Small Cell Lung ◽  
One Step
Sign in / Sign up

Export Citation Format

Share Document